Enanta Pharmaceuticals (ENTA) Gains from Investment Securities (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Gains from Investment Securities of $1.3 million for Q1 2026, up 2728.89% year-on-year from $45000.0 in Q1 2025, and up 207.7% on a QoQ basis from -$1.2 million in Q3 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Gains from Investment Securities data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities rose 2728.89% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 2728.89% YoY), and the FY2025 full-year result was $5.8 million, up 11.09% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $1.3 million, up from -$1.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $4.5 million in Q2 2023 and bottomed at -$23.7 million in Q3 2024.
- The 5-year median for Gains from Investment Securities is $323000.0 (2023), against an average of -$882250.0.
- The widest annual swing landed in 2024, when Gains from Investment Securities tumbled 581.95%; it then surged 2728.89% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at $825000.0 in 2022, then jumped by 32.36% to $1.1 million in 2023, then slumped by 98.44% to $17000.0 in 2024, then plunged by 7052.94% to -$1.2 million in 2025, then soared by 207.7% to $1.3 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.3 million (Q1 2026), -$1.2 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Sep 30, 2025 | -1.18 Mn |
| Sep 30, 2025 | -1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 45,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -23.68 Mn |
| Sep 30, 2024 | -23.68 Mn |
| Jun 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 477,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -3.47 Mn |
| Sep 30, 2023 | -3.47 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 169,000.00 |
| Mar 31, 2023 | 169,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Dec 31, 2022 | 825,000.00 |
| Sep 30, 2022 | -624,000.00 |
| Sep 30, 2022 | -624,000.00 |
| Jun 30, 2022 | 4.02 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 96,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 15.56 Mn |
| Dec 31, 2021 | 15.56 Mn |
| Sep 30, 2021 | 263,000.00 |
| Sep 30, 2021 | 263,000.00 |
| Jun 30, 2021 | 3.88 Mn |
| Jun 30, 2021 | 3.88 Mn |
| Mar 31, 2021 | 105,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Dec 31, 2020 | 534,000.00 |
| Dec 31, 2020 | 534,000.00 |
| Sep 30, 2020 | -1.18 Mn |
| Sep 30, 2020 | -1.18 Mn |
| Jun 30, 2020 | 679,000.00 |
| Jun 30, 2020 | 679,000.00 |
| Mar 31, 2020 | 866,000.00 |
| Mar 31, 2020 | 866,000.00 |
| Dec 31, 2019 | 3.45 Mn |
| Dec 31, 2019 | 3.45 Mn |
| Sep 30, 2019 | 4.23 Mn |
| Sep 30, 2019 | 4.23 Mn |
| Jun 30, 2019 | 48,000.00 |
| Jun 30, 2019 | 48,000.00 |
| Mar 31, 2019 | 2.93 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Dec 31, 2018 | -39,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Sep 30, 2018 | -9,000.00 |
| Sep 30, 2018 | -9,000.00 |
| Jun 30, 2018 | 26,000.00 |
| Jun 30, 2018 | 26,000.00 |
| Mar 31, 2018 | 2.72 Mn |
| Mar 31, 2018 | 2.72 Mn |
| Dec 31, 2017 | 466,000.00 |
| Dec 31, 2017 | 466,000.00 |
| Jun 30, 2017 | 559,019.00 |
| Jun 30, 2017 | 559,019.00 |
| Mar 31, 2017 | 105,596.00 |
| Mar 31, 2017 | 105,596.00 |
| Dec 31, 2016 | 2,029.00 |
| Dec 31, 2016 | 2,029.00 |
| Sep 30, 2016 | -1.41 Mn |
| Sep 30, 2016 | -1.41 Mn |
| Jun 30, 2016 | 495,780.00 |
| Jun 30, 2016 | 495,780.00 |
| Mar 31, 2016 | 21,635.00 |
| Mar 31, 2016 | 21,635.00 |
| Dec 31, 2015 | 50,000.00 |
| Dec 31, 2015 | 50,000.00 |
| Sep 30, 2015 | -34.74 Mn |
| Sep 30, 2015 | -34.74 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Jun 30, 2015 | 1.75 Mn |
| Mar 31, 2015 | 1.69 Mn |
| Mar 31, 2015 | 1.69 Mn |
| Dec 31, 2014 | 66,000.00 |
| Dec 31, 2014 | 66,000.00 |
| Jun 30, 2014 | 9,343.00 |
| Jun 30, 2014 | 9,343.00 |
| Mar 31, 2014 | 1.41 Mn |
| Mar 31, 2014 | 1.41 Mn |
| Dec 31, 2013 | 1.85 Mn |
| Dec 31, 2013 | 1.85 Mn |
| Sep 30, 2013 | 1.58 Mn |
| Sep 30, 2013 | 1.58 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Jun 30, 2013 | 1.69 Mn |
| Mar 31, 2013 | 167,000.00 |
| Mar 31, 2013 | 167,000.00 |
| Sep 30, 2012 | 1.77 Mn |
| Sep 30, 2012 | 1.77 Mn |